Industry News行业新闻

Home / Investor Relations投资者关系 / Industry News行业新闻

14-07-2017
Equities.com
CBMG CAR-T programs in China
19-02-2016
Financial Times
Fundraisings highlight the rise in Chinese pharma R&D
CBMG a contender
25-09-2015
China Daily
Cellular Biomedicine Group High Hopes for Future
24-06-2015
BioSpace
EXCLUSIVE: Cellular Biomedicine Group (CBMG) Ready to Hire After Snapping Up Cancer Vaccine
11-06-2015
Fierce Pharma Asia
China part of Opdivo combo trial plans as Nasdaq-listed CBMG buys cancer vaccine
11-06-2015
The Life Sciences Report
John McCamant, Medical Technology Stock Letter
10-06-2015
LifeTech Capital
Cellular Biomedicine (CBMG) Update Report
09-06-2015
BioCentury
CBMG gets NSCLC vaccine, plans combo trial with Opdivo
12-05-2015
The Life Sciences Report
Fire Up the Immune System to Fight Cancers and Boost Portfolios: John McCamant
12-02-2015
China Daily
Saving Lives and Extending Lives, Cellular Biomedicine Group Chases The Dream (Chinese content)
10-03-2014
Nature Biotechnology
Ventures focusing on gene therapy, adoptive T-cell therapy, protein homeostasis and the microbiome are among those selected by the editors in 2013's crop of startups.
20-12-2013
Science Magazine
Science's editors have chosen cancer immunotherapy as Breakthrough of the Year for 2013
24-06-2015
BioSpace
EXCLUSIVE: Cellular Biomedicine Group (CBMG) Ready to Hire After Snapping Up Cancer Vaccine
11-06-2015
Fierce Pharma Asia
China part of Opdivo combo trial plans as Nasdaq-listed CBMG buys cancer vaccine
11-06-2015
The Life Sciences Report
John McCamant, Medical Technology Stock Letter
10-06-2015
LifeTech Capital
Cellular Biomedicine (CBMG) Update Report
09-06-2015
BioCentury
CBMG gets NSCLC vaccine, plans combo trial with Opdivo
12-05-2015
The Life Sciences Report
Fire Up the Immune System to Fight Cancers and Boost Portfolios: John McCamant
12-02-2015
China Daily
拯救生命,延展生命,西比曼生物创业者的中国梦
10-03-2014
Nature Biotechnology
Ventures focusing on gene therapy, adoptive T-cell therapy, protein homeostasis and the microbiome are among those selected by the editors in 2013's crop of startups.
20-12-2013
Science Magazine
Science's editors have chosen cancer immunotherapy as Breakthrough of the Year for 2013